Atom Grants
Discover
  • Dashboard
  • Search
  • Deep Research
  • Favorites
  • Projects

    Neuromodulation/Neurostimulation Device Development for Mental Health Applications (R01 Clinical Trial Not Allowed)

    This grant supports developing advanced brain stimulation devices for mental health treatment, focusing on novel techniques with improved precision and efficacy.

    Browse similar grants
    Neuroscience Research Grants 2026
    OverviewSimilar Grants
    OverviewSimilar Grants

    Neuromodulation/Neurostimulation Device Development for Mental Health Applications (R21 Clinical Trial Not Allowed)

    This grant supports developing advanced brain stimulation devices for treating mental health disorders, focusing on novel techniques and significant improvements to existing FDA-approved devices.

    HHS-NIH11Due Nov 16, 2026· 18d$275,000

    Utilizing Invasive Recording and Stimulating Opportunities in Humans to Advance Neural Circuitry Understanding of Mental Health Disorders (R01 Clinical Trial Optional)

    Funding for invasive neural recording studies in humans to understand brain circuits related to mental health, focusing on high-impact questions.

    HHS-NIH11Due Nov 5, 2026· 7d

    Utilizing Invasive Recording and Stimulating Opportunities in Humans to Advance Neural Circuitry Understanding of Mental Health Disorders (R21 Clinical Trial Optional)

    This grant supports research using invasive brain recordings & stimulation in humans to understand the neural circuits involved in mental health disorders.

    HHS-NIH11Due Nov 16, 2026· 18d$275,000

    Early Stage Testing of Pharmacologic or Neuromodulatory Device-based Interventions for the Treatment of Mental Disorders (R33- Clinical Trial Required)

    Funding for early testing of new drug or device treatments for mental disorders to understand mechanisms and assess clinical effects.

    HHS-NIH11Due Feb 17, 2027

    Early Stage Testing of Pharmacologic or Neuromodulatory Device-based Interventions for the Treatment of Mental Disorders (R61/R33 Clinical Trial Required)

    Funding for early-stage trials testing drugs or devices for mental disorder treatment, focusing on clinical effects and underlying mechanisms.

    HHS-NIH11Due Jan 18, 2027